| Test |
In Range |
Out Of Range |
Units |
Reference |
| HNK1 (CD57) Panel |
|
|
|
|
| %CD8-/CD57+Lymphs |
5.0 |
|
% |
2.0 - 17.0 |
| Abs. CD8-CD57+Lymphs |
65 |
|
uL |
60 - 360 |
| |
| CBC With Differential/Platelet |
|
|
|
|
| WBC |
4.4 |
|
x10E3/uL |
3.4 - 10.8 |
| RBC |
|
L 3.74 |
x10E6/uL |
4.14 - 5.80 |
| Hemoglobin |
|
L 12.2 |
g/dL |
13.0 - 17.7 |
| Hrmatocrit |
|
L 35.9 |
% |
37.5 - 51.0 |
| |
| 96 |
|
fL |
79 - 97 | |
| MCH |
32.6 |
|
pg |
26.6 - 33.0 |
| MCHC |
34.0 |
|
g/dL |
31.5 - 35.7 |
| RDW |
11.9 |
|
% |
11.6 - 15.4 |
| Platelets |
208 |
|
x10E3/uL |
150 - 450 |
| |
| Neutrophils |
57 |
|
% |
|
| Lymphs |
28 |
|
% |
|
| Monpcytes |
9 |
|
% |
|
| Eos |
4 |
|
% |
|
| Basos |
1 |
|
% |
|
| |
| Neutrophils (absolute) |
2.5 |
|
x10E3/uL |
1.4 - 7.0 |
| Lymphs (absolute) |
1.3 |
|
x10E3/uL |
0.7 - 3.1 |
| Monocytes (sbsolute) |
0.4 |
|
x10E3/uL |
0.1 - 0.9 |
| Eos (absolute) |
0.2 |
|
x10E3/uL |
0.0 - 0.4 |
| Baso (absolute) |
0.0 |
|
x10E3/uL |
0.0 - 0.2 |
| Immature Granulocytes |
1 |
|
% |
|
| Immature Grans (Abs) |
0.0 |
|
x10E3/uL |
0.0 - 0.1 |
| |
| Amitriptyline (Elevil), Serum |
86 |
|
ng/mL |
|
| Nortriptyline, Serum |
33 |
|
ng/mL |
|
| Total (Ami+Nor) |
119 |
|
ng/mL |
80 - 200 |
| EBV PCR Quant (Whole Blood) |
|
|
|
|
| EBV PCR Quant (Whole Blood) |
Negative |
|
copies/mL |
Negative |
| log10 EBV DNA Qn PCR |
Unable to calculate result since non-numeric result obtained for component test. |
| EBV Nuclear Antigen Ab,IgG |
|
|
|
|
| EBV Nuclear Antigen Ab, IgG |
< 18.00 |
|
U/mL |
0.0 - 17.9 |
| EBV Ab VCA, IgG |
|
|
|
|
| EBV Ab VCA, IgG |
|
458.0 H |
U/mL |
0.0 - 17.9 |
| EBV Early Antigen Ab, IgG |
|
|
|
|
| EBV Early Antigen Ab, IgG |
< 9.0 |
|
U/mL |
0.0 - 8.9 |
| |
| EBV Ab VCA, IgM |
|
|
|
|
| EBV Ab VCA, IgM |
< 36.0 |
|
U/mL |
0.0 - 35.9 |
| |
| D-Dimer |
|
|
|
|
| D-Dimer |
0.57 |
|
mg/L FEU |
0.00 - 0.82 |
| |
According to the assay manufacturer's insert, a normal (< 0.50 mg/L FEU) D-dimer result in conjunction with a non-high clinical probability assessment, excludes deep vein thrombosis (DVT) and pulmonary embolism (PE) with high sensitivity.
D-dimer values increase with age and this can make
VTE exclusion of an older population difficult. To address this, the American College of Physicians, based on best available evidence and recent guidelines, recommends that clinicians use age-adjusted D-dimer threasholds in patients greater than 50 years of age with: a) a low probabliity of PE who do not meet all Pulmonary Embolism Rule Out Criteria, or b) in those with intermediate probablility of PE. The formula for an age-adjusted D-dimer cut-off is "age/100", For esample, a 60 year old patient would have an age=adjusted cut-off of 0.60 mg/L FEU and an 80 year old 0.80 mg/L FEU. |
| |
| VEGF, Serum |
|
|
|
&nbssp; |
| VEGF, Serum |
|
L 47 |
pg/mL |
62 - 707 |
| |
R and D Systems Quantikine Enzyme Immunoassay (EIA) Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. |
| |
| Fibrinogen Activity |
|
|
|
|
| Fibrinogen Activity |
237 |
|
mg/dL |
193-507 |
| |
| Magnesium, RBC |
|
|
|
|
| Maagnesium, RBC |
5.0 |
|
mg/dL |
3.7 - 7.0 |